Raymond James & Associates’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,416
| Closed | -$4K | – | 3497 |
|
|
2018
Q4 | $4K | Hold |
1,416
| – | – | ﹤0.01% | 3421 |
|
|
2018
Q3 | $10K | Sell |
1,416
-3
| -0.2% | -$21 | ﹤0.01% | 3486 |
|
|
2018
Q2 | $11K | Sell |
1,419
-179
| -11% | -$1.39K | ﹤0.01% | 3443 |
|
|
2018
Q1 | $56K | Hold |
1,598
| – | – | ﹤0.01% | 3276 |
|
|
2017
Q4 | $68K | Buy |
1,598
+185
| +13% | +$7.87K | ﹤0.01% | 3202 |
|
|
2017
Q3 | $61K | Sell |
1,413
-9
| -0.6% | -$389 | ﹤0.01% | 3178 |
|
|
2017
Q2 | $53K | Buy |
1,422
+637
| +81% | +$23.7K | ﹤0.01% | 3116 |
|
|
2017
Q1 | $43K | Buy |
785
+53
| +7% | +$2.9K | ﹤0.01% | 3078 |
|
|
2016
Q4 | $39K | Sell |
732
-33
| -4% | -$1.76K | ﹤0.01% | 3031 |
|
|
2016
Q3 | $46K | Buy |
+765
| New | +$46K | ﹤0.01% | 3010 |
|
|
2015
Q3 | – | Sell |
-775
| Closed | -$293K | – | 2277 |
|
|
2015
Q2 | $293K | Sell |
775
-130
| -14% | -$49.1K | ﹤0.01% | 2283 |
|
|
2015
Q1 | $378K | Buy |
+905
| New | +$378K | ﹤0.01% | 2138 |
|